Nutex Health Inc. (NASDAQ:NUTX) Short Interest Update

Key Points

• Short interest in Nutex Health Inc. (NASDAQ:NUTX) increased by 58.0% in July, totaling 817,600 shares, which represents 23.1% of the company's stock sold short.
• The company reported impressive quarterly earnings, with a net margin of 10.76% and EPS of $2.56, significantly surpassing analysts' expectations.
• Nutex Health's stock price saw a 2.7% increase recently, with a market cap of approximately $520.36 million and a P/E ratio of 7.87.

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) was the target of a significant growth in short interest in July. As of July 15th, there was short interest totaling 817,600 shares, agrowthof58.0% from the June 30th total of 517,500 shares. Based on an average trading volume of 225,500 shares, the short-interest ratio is presently 3.6 days. Currently,23.1% of the shares of the company are short sold. Currently,23.1% of the shares of the company are short sold. Based on an average trading volume of 225,500 shares, the short-interest ratio is presently 3.6 days.

Institutional Investors Weigh In On Nutex Health

Several institutional investors and hedge funds have recently bought and sold shares of NUTX. Bank of America Corp DE lifted its holdings in shares of Nutex Health by 6,590.3% in the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock worth $66,000 after acquiring an additional 2,043 shares during the last quarter. Police & Firemen s Retirement System of New Jersey bought a new position in shares of Nutex Health in the second quarter worth about $97,000. KLP Kapitalforvaltning AS bought a new position in shares of Nutex Health in the second quarter worth about $112,000. AlphaQuest LLC bought a new position in shares of Nutex Health in the second quarter worth about $198,000. Finally, Northern Trust Corp bought a new position in shares of Nutex Health in the fourth quarter worth about $200,000. Institutional investors own 5.32% of the company's stock.

Nutex Health Price Performance

NUTX traded down $1.31 on Friday, hitting $87.92. 108,634 shares of the stock were exchanged, compared to its average volume of 283,919. Nutex Health has a 12 month low of $8.25 and a 12 month high of $184.27. The business has a 50-day moving average of $113.18 and a two-hundred day moving average of $98.27. The company has a debt-to-equity ratio of 1.02, a current ratio of 2.27 and a quick ratio of 2.26. The firm has a market capitalization of $488.84 million, a price-to-earnings ratio of 7.39 and a beta of 0.05.

Nutex Health (NASDAQ:NUTX - Get Free Report) last posted its quarterly earnings data on Tuesday, May 13th. The company reported $2.56 earnings per share for the quarter, topping the consensus estimate of ($0.15) by $2.71. Nutex Health had a net margin of 10.76% and a return on equity of 42.08%. The business had revenue of $211.79 million during the quarter, compared to analysts' expectations of $81.09 million.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the stock. Benchmark upped their price target on shares of Nutex Health from $150.00 to $300.00 and gave the company a "buy" rating in a research note on Thursday, May 15th. Wall Street Zen downgraded shares of Nutex Health from a "strong-buy" rating to a "buy" rating in a research note on Thursday, May 22nd. Finally, Maxim Group upped their price target on shares of Nutex Health from $100.00 to $225.00 and gave the company a "buy" rating in a research note on Tuesday, May 20th.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.